SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001546927-15-000265
Filing Date
2015-10-23
Accepted
2015-10-23 11:08:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 camberprotalixform13gafiled.htm SC 13G/A 41885
2 JOINT FILING AGREEMENT camberprotalix13gaex1filed.htm EX-1 2590
  Complete submission text file 0001546927-15-000265.txt   46229
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 151172114
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A